Dermatology Search
Dermatology Dermatology
urticaria
URTICARIA
Urticaria is characterized by sudden appearance of wheals and/or angioedema.
The intensity of the pruritus varies but may be severe enough to disrupt sleep, work or school.
It is classified acute if the urticaria has been present for <6 weeks and chronic if >6 weeks. A specific cause is more likely to be identified in acute cases.
It can be triggered by immunological or nonimmunological mechanism.
Drug Information

Indication: Relief of symptoms associated w/ allergic rhinitis & common cold including nasal congestion, sneezing, rhi...

Indication: Relief of symptoms associated w/ allergic rhinitis & common cold including nasal congestion, sneezing, rhi...

Indication: Symptomatic relief of allergic rhinitis eg, sneezing, nasal discharge & itching, as well as ocular itching...

Indication: Symptomatic treatment of seasonal & perennial allergic rhinitis & urticaria of allergic origin.

Indication: Rapid relief of symptoms associated w/ allergic rhinitis eg, sneezing, nasal discharge & itching, congesti...

Aerius D-12
desloratadine + pseudoephedrine sulphate

Indication: Symptomatic relief of nasal & non-nasal allergic rhinitis including nasal congestion in adults & child...

Indication: Relief of symptoms associated w/ allergic rhinitis & common cold eg, nasal congestion, sneezing, rhinorrhe...

Indication: Symptomatic treatment of perennial & seasonal allergic rhinitis, vasomator rhinitis, allergic conjunctivit...

Indication: Symptomatic treatment of seasonal & perennial allergic rhinitis & urticaria.

Indication: Prophylaxis & chronic treatment of asthma in adults & childn ≥12 mth. Relief of daytime & night...

1  /  16
1  /  16
Editor's Recommendations
Most Read Articles
Every-2-month cabotegravir + rilpivirine feasible for HIV treatment
Pearl Toh, 2 days ago
Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.
Why are there fewer COVID-19 cases in children?
Stephen Padilla, 19 Mar 2020
The assumption that children are less vulnerable to the coronavirus disease 2019 (COVID-19) compared to adults is not quite true and may even be dangerous, suggests a recent study.
Sustained lopinavir use may improve condition of COVID-19 patients
22 Mar 2020
Sustained use of lopinavir-combined regimen appears to confer benefits among patients with the novel coronavirus disease (COVID-19), with improvement possibly indicated by increasing eosinophils, suggests a recent study.
13 ways to fight COVID-19
5 days ago
COVID-19 is a novel disease, with no existing immunity. The virus can be transmitted from person to person, quickly and exponentially. Here’s what we can do to slow down the spread, if not contain the outbreak.